We report a nanoparticulate system capable of targeting the heart after myocardial infarction (MI). Targeting is based on overexpression of angiotensin II type 1 (AT1) receptor in the infarcted heart. Liposomes 142 nm in diameter were conjugated with a ligand specific to AT1. The nanoparticles were able to specifically target cardiac cells in vitro, and in the infarcted heart after intravenous injection in vivo. This system may be useful for delivering therapeutic agents specifically to the infarcted heart. © 2011 American Chemical Society.
CITATION STYLE
Dvir, T., Bauer, M., Schroeder, A., Tsui, J. H., Anderson, D. G., Langer, R., … Kohane, D. S. (2011). Nanoparticles targeting the infarcted heart. Nano Letters, 11(10), 4411–4414. https://doi.org/10.1021/nl2025882
Mendeley helps you to discover research relevant for your work.